EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oral microbiota in gastric cancer: from pathobiont mechanisms to microbiome-targeted therapeutics

Xiaoqing Tao, Mingyue Liu, Xiaoman Liu, Feifei Zhou, Hongwei Xu

Frontiers in Cellular and Infection Microbiology · 11.11.2026 · 16

DOI: 10.3389/fcimb.2026.1999791 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 11.11.2026. Verfasst von Xiaoqing Tao und 4 weiteren Autor:innen. Die Arbeit nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Helicobacter pylori is a well-established driver of gastric cancer (GC). However, emerging evidence highlights the oral-gastric axis as a previously underappreciated frontier in gastric carcinogenesis. In this review, we comprehensively summarize how oral microbiota dysbiosis may promote​ GC initiation and progression. Current literature indicates that oral pathobionts frequently translocate to the gastric niche. These microbes may contribute to tumorigenesis by sustaining chronic mucosal inflammation. They also potentially modulate tumor immune evasion and may promote cellular metabolic reprogramming. Furthermore, specific oral taxa exhibit profound synergistic crosstalk with H. pylori . This microbial synergy exacerbates the hostile tumor microenvironment and accelerates malignant transformation. Unraveling these multi-level regulatory networks underscores the immense clinical translational value of the oral-gastric axis. Specifically, oral microbial signatures offer great promise as non-invasive biomarkers for early diagnostic screening. They concurrently represent novel targets for precision microecological therapies. Finally, we identify critical knowledge gaps to guide future rigorous investigations in this rapidly evolving field.

Zitieren

APA

Tao, X., Liu, M., Liu, X., Zhou, F., & Xu, H. (2026). Oral microbiota in gastric cancer: from pathobiont mechanisms to microbiome-targeted therapeutics. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1999791

Vancouver

Tao X, Liu M, Liu X, Zhou F, Xu H. Oral microbiota in gastric cancer: from pathobiont mechanisms to microbiome-targeted therapeutics. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1999791

BibTeX
@article{Tao2026,
  author = {Tao, Xiaoqing and Liu, Mingyue and Liu, Xiaoman and Zhou, Feifei and Xu, Hongwei},
  title = {Oral microbiota in gastric cancer: from pathobiont mechanisms to microbiome-targeted therapeutics},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1999791}
}
Kostenlos starten →